2016 PGRN-ASHG Symposium Information | Oct. 17-18, 2016; Vancouver, Canada

Have you heard? The Pharmacogenomics Research Network (PGRN) is hosting the PGRN-ASHG Symposium, entitled “The Expanding Universe of Pharmacogenomics,” immediately prior to the ASHG Annual Meeting on Monday, October 17, 2016 and Tuesday, October 18, 2016 in Vancouver, Canada.

This symposium, organized by the PGRN and open to all ASHG attendees, PGRN members and all other interested parties, explores current topics in pharmacogenomics with sessions on innovative approaches for identifying genes that influence drug response, the role of pharmacogenomics in drug discovery, technologies used in pharmacogenomic studies and the evolution of pharmacogenes. In addition, there will be an interactive panel discussion with diverse stakeholders on issues affecting the clinical implementation of pharmacogenomic testing.

More details, including the agenda, list of speakers and the link to register can be found on the PGRN website at  Please note that there is no registration fee for this symposium.

If you have any questions or for more information, please visit PGRN website at or contact

In the News

Here's what's happening with eMerge:


Read the full press release here. Congratulations to all the sites in the next round of eMERGE! The new clinical sites will be led by: Iftikhar J. Kullo, M.D., at Mayo Clinic, Rochester, Minnesota Dan M. Roden, M.D., at Vanderbilt University Medical Center, Nashville, Tennessee Elizabeth W. Karlson, M.D., at Brigham and Women’s Hospital, Boston Rex […]


The eMERGE Network is excited to share that the MCS NT304, Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in the eMERGE Network; was published on May 7th to American Journal of Human Genetics.


Two companion RFAs for the PRS Diversity Consortium are now published: Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Study Sites (U01 Clinical Trial Not Allowed): Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Coordinating Center (U01 Clinical Trial Not Allowed): The goal […]


Notice to Encourage Eligible NHGRI Awardees to Apply for PA-18-906 “Research Supplements to Promote Diversity in Health-Related Research” PIs of active NHGRI research grants can apply; identify eligible individuals, including those from underrepresented groups, for support and mentorship under the auspices of this supplement opportunity. Supplement can support individuals from the undergraduate to the […]